Aridis Pharmaceuticals Inc (NASDAQ:ARDS)
| 1.25 Delayed Data As of May 17 |  +0.19 / +17.92%Today’s Change | 0.88 Today|||52-Week Range 7.72 | -46.35% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 22.0K | 1.0M | 1.4M | 1.0M | |
| Depreciation And Amortization | 73.0K | 74.0K | 82.0K | 83.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 4.5M | 7.6M | 6.9M | 8.7M | ||
| Research And Development | 3.9M | 6.9M | 5.6M | 7.1M | ||
| Total Operating Expenses | 4.6M | 7.6M | 7.0M | 8.8M | ||
| Non-Operating Expenses | Operating Income | -4.6M | -6.6M | -5.6M | -7.7M | |
| Extraordinary Credit | 3.1M | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | -1.4M | 0.00 | 0.00 | ||
| Pre-Tax Equity Earnings | 0.00 | -20.0K | -19.0K | -442.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -1.4M | -7.9M | -5.4M | -8.1M | |
| Preferred Dividend | -535.0K | -5.0K | 0.00 | 0.00 | ||
| Net Income | -1.4M | -7.9M | -5.4M | -8.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 8.2M | 4.0M | 8.1M | 8.1M | |
| Shares To Calculate EPS Diluted | 8.2M | 4.0M | 8.1M | 8.1M | ||
| Earnings Per Share | EPS | -$0.24 | -$1.97 | -$0.67 | -$0.99 | |
| EPS Diluted | -$0.24 | -$1.97 | -$0.67 | -$0.99 | ||
